| The clinical impact of [(18)F]FDG PET/CT for the management of recurrent endometrial cancer: correlation with clinical and histological findings. | |
| | |
MedLine Citation:
|
PMID: 18180917 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
PURPOSE: The purpose of this study was to evaluate the accuracy of integrated positron emission tomography (PET) and computed tomography (CT) for the identification of suspected recurrent endometrial cancer after treatment. METHODS: Thirty-one women (median age, 53 years) with endometrial cancer treated by primary staging laparotomy who had [(18)F]fluorodeoxyglucose (FDG) PET/CT performed for suspected recurrence were retrospectively reviewed. The findings of the PET/CT scans were compared, with the histological examination after a surgical biopsy in 20 cases and with clinical follow-up in 11 cases to determine the diagnostic accuracy of PET/CT. RESULTS: Twelve (38.7%) of the 31 patients had a documented recurrence by surgical biopsy or clinical follow-up, and 19 (61.3%) had no evidence of recurrence. Of the 12 patients with recurrent disease, nine (75.0%) women were confirmed to have a recurrence by surgical biopsy. A close correlation was found between the PET/CT and histological or clinical analyses (kappa = 0.933, p < 0.001). The overall sensitivity, specificity, accuracy, positive predictive value, negative predictive value, and accuracy of PET/CT were 100, 94.7, 92.3, 100, and 96.8%, respectively. The PET/CT results modified the diagnostic or treatment plan in seven (22.6%) patients, resulting in five (16.1%) patients undergoing previously unplanned therapeutic procedures and eliminating previously planned diagnostic procedures in two (6.5%) patients. Patients with negative PET/CT scans showed significantly better progression-free survival than those with positive scans (p = 0.015). CONCLUSION: Integrated PET/CT appears to be highly sensitive, specific, and accurate as a post-therapy surveillance modality for endometrial cancer in well-selected patients. The PET/CT might be used to improve patient surveillance and prognosis. |
| | |
Authors:
|
Hyun Hoon Chung; Won Jun Kang; Jae Weon Kim; Noh-Hyun Park; Yong-Sang Song; June-Key Chung; Soon-Beom Kang |
Related Documents
:
|
19139187 - 18f-fdg pet and pet/ct in the evaluation of cancer treatment response. 16635407 - The role of 11c-choline positron emission tomography-computed tomography and videomedia... 16240327 - Planned neck dissection following chemoradiotherapy for advanced head and neck cancer: ... 17581717 - Diagnostic performance of ct, pet, side-by-side, and fused image interpretations for re... 16239657 - Real-time magnetic resonance imaging aids prenatal diagnosis of isolated cleft palate. 2805537 - The incidence and etiology of the ventilation/perfusion reverse mismatch defect. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2008-01-08 |
Journal Detail:
|
Title: European journal of nuclear medicine and molecular imaging Volume: 35 ISSN: 1619-7070 ISO Abbreviation: Eur. J. Nucl. Med. Mol. Imaging Publication Date: 2008 Jun |
Date Detail:
|
Created Date: 2008-05-14 Completed Date: 2008-10-14 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101140988 Medline TA: Eur J Nucl Med Mol Imaging Country: Germany |
Other Details:
|
Languages: eng Pagination: 1081-8 Citation Subset: IM |
Affiliation:
|
Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Chongno-gu, Seoul, 110-744, South Korea. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Endometrial Neoplasms / diagnosis*, therapy* Female Fluorodeoxyglucose F18 / diagnostic use* Humans Middle Aged Neoplasm Recurrence, Local / diagnosis*, prevention & control* Outcome Assessment (Health Care) / methods* Positron-Emission Tomography / methods* Radiopharmaceuticals / diagnostic use Reproducibility of Results Sensitivity and Specificity Statistics as Topic Tomography, X-Ray Computed / methods* Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Radiopharmaceuticals; 63503-12-8/Fluorodeoxyglucose F18 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Impact of aneurysmal geometry on intraaneurysmal flow: a computerized flow simulation study.
Next Document: Brain MRI and SPECT in the diagnosis of early neurological involvement in Wilson's disease.